Clinical Trials Logo

Filter by:
NCT ID: NCT04603053 Completed - Anxiety Disorders Clinical Trials

Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT

Start date: November 9, 2020
Phase: N/A
Study type: Interventional

Washington University will evaluate the acceptability and effectiveness of a mobile health (mHealth) intervention to provide cognitive behavioral therapy for adolescents with depression.

NCT ID: NCT04603027 Completed - Psoriasis Clinical Trials

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Start date: September 21, 2020
Phase: Phase 2
Study type: Interventional

This Phase 2 study has been designed to investigate the clinical safety and efficacy of EDP1815 and to identify an optimal dose in subjects with mild to moderate psoriasis.

NCT ID: NCT04602806 Completed - Clinical trials for Traumatic Brain Injury

Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1

Start date: June 1, 2021
Phase:
Study type: Observational

This study is being conducted to validate early and ultra-early blood-based and novel imaging biomarkers of Diffuse Axonal Injury (DAI), Microvascular Injury (MVI), and neuroinflammation that may serve as predictive and pharmacodynamic biomarkers in a new cohort of moderate-severe TRACK-TBI subjects. The study team will enroll a cohort of moderate to severe TBI subjects (N=50), stratified according to VA/DoD criteria for these injury severities through the existing TRACK-TBI network sites to obtain novel advanced neuroimaging and more frequent biomarker sampling. Subjects will be assessed over 3 months.

NCT ID: NCT04602650 Completed - Diabetes Clinical Trials

Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent

Start date: January 14, 2021
Phase:
Study type: Observational

Type 2 diabetes (T2D) predisposes individuals to neurodegeneration and dementia, including Alzheimer's Disease (AD); yet the link between metabolic and neurodegenerative disorders remains unknown. Here, the investigators will study a well-defined human population with increased prevalence and early onset of both T2D and AD, individuals of Mexican descent living in South Texas. The study will begin to explore the possibility that disruption of the structure of the bacterial community residing in the gut in type 2 diabetic individuals of Mexican descent living in South Texas is directly related to the increased prevalence of early onset AD in this population. In this study, the investigators will perform gene sequencing on DNA isolated from fecal samples to identify and compare the populations of bacteria living in individuals with T2D versus non-diabetic controls. The investigators will analyze the findings to determine if the community structure of the gut microbiome of individuals of Mexican descent with T2D is significantly altered compared to that of non-diabetics within the same population. The investigators' findings could lead to the identification of early indicators of dementia onset as well as novel therapies for treating metabolic and neurodegenerative diseases.

NCT ID: NCT04602624 Completed - Alzheimer Disease Clinical Trials

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Start date: February 2, 2021
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate the safety and tolerability of SAGE-718 and its effects on cognitive and neuropsychiatric symptoms in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease (AD).

NCT ID: NCT04602611 Completed - Clinical trials for Gastrointestinal Cancer

Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers

ACCESS
Start date: November 3, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about the impact of the Oncology Nurse Navigation program on the frequency of Emergency Department, urgent care visits and inpatient hospital admissions; and overall survival rate at 6 months. The investigators aim to understand if prompt and effective coordination of care provided by Oncology Nurse Navigation (ONN) service will reduce the number of avoidable, unplanned ED visits and hospitalizations, as well as adding measurable value to cancer care, and improve patient overall survival.

NCT ID: NCT04602546 Completed - Anesthesia Clinical Trials

Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER)

OLIVER
Start date: February 9, 2021
Phase: N/A
Study type: Interventional

To investigate the relationship between BIS™ and inhaled anesthetics across a wide range of anesthetic concentration and hypnotic states, and to provide evidence to support BIS™ performance in use with Isoflurane, Sevoflurane and Desflurane in combination with opioids.

NCT ID: NCT04602455 Completed - Loneliness Clinical Trials

The Impact of Heartfulness Program on Loneliness in High School Students in the US

Start date: June 23, 2020
Phase: N/A
Study type: Interventional

This quantitative study assesses the baseline loneliness scores in all the high school students in the US. Assessments at baseline will include the UCLA loneliness scale. The Google form questionnaire will ask the high schoolers for their email address and their parent's email address (if they are under 18). The form will also include a question eliciting interest in participation in the 4-weeks Heartfulness program. The program will include tools that promote a heart-based nurturing environment focusing on relaxation, positivity, and developing growth mindsets.

NCT ID: NCT04602221 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

Start date: December 1, 2020
Phase: Phase 1
Study type: Interventional

The main objective of this trail is to investigate if and to what extent BI 409306, BI 425809 and lamotrigine attenuate ketamine induced cognitive deficits.

NCT ID: NCT04601948 Completed - Cancer Clinical Trials

AYActive Study! A Physical Health Activity Intervention

Start date: November 6, 2019
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics.